Literature DB >> 16121382

Replication of respiratory viruses, particularly influenza virus, rhinovirus, and coronavirus in HuH7 hepatocarcinoma cell line.

François Freymuth1, Astrid Vabret, Flore Rozenberg, Julia Dina, Joëlle Petitjean, Stéphanie Gouarin, Loïc Legrand, Sandrine Corbet, Jacques Brouard, Pierre Lebon.   

Abstract

Detection of viral antigens and isolation methods has long been used for the diagnosis of respiratory virus infections. The objective was to determine the ability of HuH7 cells to support the replication of prototype and wild strains of respiratory viruses. The cell culture-adapted strains of influenza viruses A and B, parainfluenza viruses 1-4, respiratory syncytial viruses A and B, both strains of the human metapneumoviruses, numerous rhinoviruses, most of the adenoviruses, coronaviruses 229E and OC43, and a number of enteroviruses (poliovirus type 3, coxsackie virus B1, echovirus type 30) replicate in HuH7. The kinetic study of the replication of influenza A and B viruses showed that there were infected cells in HuH7 and MDCK lines as early as 24 hr post-infection. However, the replication of influenza A and B viruses was more rapid and intense on MDCK cells than on HuH7 cells. During the three winters of 1999-2000, 2000-2001, and 2001-2002, of the 1,226 (23.3%) direct fluorescent assay-positive nasal aspirates from children admitted to hospital, 788 were positive for respiratory syncytial virus, 228 for influenza virus, 133 for parainfluenza virus, and 77 for adenovirus. Of the 4,032 direct fluorescent assay-negative nasal aspirates, 571 virus isolates were identified by using HuH7 cell culture; 272 rhinoviruses, 100 influenza viruses A and B, 85 enteroviruses, 40 adenoviruses, 35 coronaviruses, 31 parainfluenza viruses, and 10 respiratory syncytial viruses. Interestingly, 100/328 (30.5%) influenza viruses A and B, 40/189 (21.1%) adenoviruses, and 31/164 (19%) parainfluenza viruses type 1-3, not detected by direct fluorescent assay, were identified by isolation in HuH7 cell culture. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16121382      PMCID: PMC7166344          DOI: 10.1002/jmv.20449

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  28 in total

Review 1.  Molecular techniques should now replace cell culture in diagnostic virology laboratories.

Authors:  B Carman
Journal:  Rev Med Virol       Date:  2001 Nov-Dec       Impact factor: 6.989

2.  Canine kidney cell line for isolation of respiratory viruses.

Authors:  H Meguro; J D Bryant; A E Torrence; P F Wright
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

3.  Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples.

Authors:  B Schweiger; I Zadow; R Heckler; H Timm; G Pauli
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Use of A-549 cells in a clinical virology laboratory.

Authors:  G L Woods; A Young
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

5.  Sensitivity of NCI-H292 human lung mucoepidermoid cells for respiratory and other human viruses.

Authors:  J C Hierholzer; E Castells; G G Banks; J A Bryan; C T McEwen
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

6.  Comparison of immunofluorescence and isolation techniques in the diagnosis of respiratory viral infections of children.

Authors:  R E Fulton; P J Middleton
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

7.  Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Authors:  V Lohmann; F Körner; J Koch; U Herian; L Theilmann; R Bartenschlager
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

8.  Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children.

Authors:  F Freymuth; A Vabret; J Brouard; F Toutain; R Verdon; J Petitjean; S Gouarin; J F Duhamel; B Guillois
Journal:  J Clin Virol       Date:  1999-08       Impact factor: 3.168

9.  Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction.

Authors:  A Vabret; F Mouthon; T Mourez; S Gouarin; J Petitjean; F Freymuth
Journal:  J Virol Methods       Date:  2001-09       Impact factor: 2.014

10.  Coronavirus 229E-related pneumonia in immunocompromised patients.

Authors:  Frédéric Pene; Annabelle Merlat; Astrid Vabret; Flore Rozenberg; Agnès Buzyn; François Dreyfus; Alain Cariou; François Freymuth; Pierre Lebon
Journal:  Clin Infect Dis       Date:  2003-09-08       Impact factor: 9.079

View more
  19 in total

1.  Green fluorescent protein reporter system with transcriptional sequence heterogeneity for monitoring the interferon response.

Authors:  Linah Mahmoud; Maher Al-Saif; Haitham M Amer; Mustafa Sheikh; Fahad N Almajhdi; Khalid S A Khabar
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Evaluation of the one-step multiplex real-time reverse transcription-PCR ProFlu-1 assay for detection of influenza A and influenza B viruses and respiratory syncytial viruses in children.

Authors:  Jérôme Legoff; Rachid Kara; Florence Moulin; Ali Si-Mohamed; Anne Krivine; Laurent Bélec; Pierre Lebon
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

3.  Human Cytokinome Analysis for Interferon Response.

Authors:  Suhad Al-Yahya; Linah Mahmoud; Fahad Al-Zoghaibi; Abdullah Al-Tuhami; Haithem Amer; Fahad N Almajhdi; Stephen J Polyak; Khalid S A Khabar
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 4.  Human rhinoviruses.

Authors:  Samantha E Jacobs; Daryl M Lamson; Kirsten St George; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

5.  Norwalk virus RNA is infectious in mammalian cells.

Authors:  Susana Guix; Miyuki Asanaka; Kazuhiko Katayama; Sue E Crawford; Frederick H Neill; Robert L Atmar; Mary K Estes
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 6.  The use of Nanotrap particles for biodefense and emerging infectious disease diagnostics.

Authors:  Nazly Shafagati; Alexis Patanarut; Alessandra Luchini; Lindsay Lundberg; Charles Bailey; Emanuel Petricoin; Lance Liotta; Aarthi Narayanan; Benjamin Lepene; Kylene Kehn-Hall
Journal:  Pathog Dis       Date:  2014-03-20       Impact factor: 3.166

7.  Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.

Authors:  Giuseppe Gerna; Giulia Campanini; Francesca Rovida; Elena Percivalle; Antonella Sarasini; Antonietta Marchi; Fausto Baldanti
Journal:  J Med Virol       Date:  2006-07       Impact factor: 2.327

8.  Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study.

Authors:  Cédric Daubin; Jean-Jacques Parienti; Sabine Fradin; Astrid Vabret; Michel Ramakers; Nicolas Terzi; François Freymuth; Pierre Charbonneau; Damien du Cheyron
Journal:  BMC Infect Dis       Date:  2009-09-21       Impact factor: 3.090

9.  Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.

Authors:  Cédric Daubin; Jean-Jacques Parienti; Astrid Vabret; Michel Ramakers; Sabine Fradin; Nicolas Terzi; François Freymuth; Pierre Charbonneau; Damien du Cheyron
Journal:  BMC Infect Dis       Date:  2008-10-23       Impact factor: 3.090

10.  Development of duplex real-time PCR for detection of two DNA respiratory viruses.

Authors:  Julia Dina; Emilie Nguyen; Stephanie Gouarin; Joelle Petitjean; Jean-Jacques Parienti; Delphine Nimal; Jacques Brouard; François Freymuth; Astrid Vabret
Journal:  J Virol Methods       Date:  2009-08-03       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.